These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Disability index of hands and feet in patients attending an urban leprosy clinic. Thappa DM; Kaur S; Sharma VK Indian J Lepr; 1990; 62(3):328-37. PubMed ID: 2262718 [TBL] [Abstract][Full Text] [Related]
7. Classification of disabilities resulting from leprosy, for use in control projects. Bull World Health Organ; 1969 Apr; 40(4):609-12. PubMed ID: 5306725 [No Abstract] [Full Text] [Related]
8. Terminology in leprosy rehabilitation and guidelines for nerve function assessment. Brandsma JW Trop Geogr Med; 1994; 46(2):88-92. PubMed ID: 8079397 [No Abstract] [Full Text] [Related]
9. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients. Reed NK; van Brakel WH; Reed DS Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):328-36. PubMed ID: 9401485 [TBL] [Abstract][Full Text] [Related]
10. An appraisal of use of the classifications of disabilities resulting from leprosy in field work and suggestions for improvement. Hasan S Lepr India; 1982 Jan; 54(1):135-42. PubMed ID: 7098436 [No Abstract] [Full Text] [Related]
11. A Delphi exercise to refine the WHO three-point disability grading system for leprosy, and to develop guidelines to promote greater accuracy and reliability of WHO disability recording. Cross H Lepr Rev; 2014 Mar; 85(1):18-28. PubMed ID: 24974439 [TBL] [Abstract][Full Text] [Related]
12. The clinical spectrum of leprosy and a practical approach to classification. de Soldenhoff R Trop Geogr Med; 1994; 46(2):55-8. PubMed ID: 8079390 [No Abstract] [Full Text] [Related]
13. The World Health Organization's International Classification of Functioning, Disability and Health: implications for clinical and research practice in the field of augmentative and alternative communication. Raghavendra P; Bornman J; Granlund M; Björck-Akesson E Augment Altern Commun; 2007 Dec; 23(4):349-61. PubMed ID: 17999247 [TBL] [Abstract][Full Text] [Related]
15. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration. Meima A; van Veen NH; Richardus JH Trop Med Int Health; 2008 Feb; 13(2):241-6. PubMed ID: 18304271 [TBL] [Abstract][Full Text] [Related]
16. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil. De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579 [TBL] [Abstract][Full Text] [Related]
17. WHO expert committee on leprosy. World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944 [No Abstract] [Full Text] [Related]
18. WHO surveys of disabilities in leprosy in northern Nigeria (Katsina), Cameroon and Thailand (Khon Kaen). Martinez Dominguez V; Bechelli LM; Patwary KM Int J Lepr Other Mycobact Dis; 1966; 34(3):244-54. PubMed ID: 5950421 [No Abstract] [Full Text] [Related]
19. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser; 1998; 874():1-43. PubMed ID: 9627517 [TBL] [Abstract][Full Text] [Related]
20. Disabilities of hands, feet and eyes in newly diagnosed leprosy patients in eastern Nepal. Schipper A; Lubbers WJ; Hogeweg M; De Soldenhoff R Lepr Rev; 1994 Sep; 65(3):239-47. PubMed ID: 8942154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]